| BSX |
Report |
Organic revenue growth |
IN-LINE |
pred ~5.40% vs. cons 5.45% |
LOW |
| BSX |
Report |
EP revenue |
IN-LINE |
pred ~$900M vs. cons $906.2M |
LOW |
| BSX |
Report |
WATCHMAN revenue |
MISS |
pred ~$505M vs. cons $513.7M |
LOW |
| BSX |
Guide |
FY26 organic growth |
BETTER |
guide 6.5%-8.0% vs. cons 6.32% |
LOW |
| BSX |
Guide |
FY26 adjusted operating EPS |
UNCHANGED |
guide $3.34-$3.41 vs. cons $3.353 |
LOW |
| BSX |
Guide |
Q3 WATCHMAN trajectory |
LOWER |
guide flat sequential, ~$505M vs. cons $520.0M |
LOW |
| BSX |
Return |
Day-1 residual (stock − beta × S&P 500) |
-4.0% |
— |
LOW |
| BSX |
Return |
5-day cumulative residual |
-6.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — near-term LAAC weakness drives revisions |
LOW |